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Agglutination reactions obtained with three commercial latex reagents for detecting Escherichia coli O157
antigen (Oxoid Diagnostic Reagents, Hampshire, England; Pro-Lab Inc., Richmond Hill, Ontario, Canada;
and Remel Microbiology Products, Lenexa, Kans.) and one for detecting H7 antigen (Remel) were compared
with those obtained by standard serologic methods by using the Centers for Disease Control and Prevention
(CDC) reference antisera for O157 and H7 antigens. For 159 strains of E. coli and related organisms, the
Oxoid, Pro-Lab, and Remel O157 latex reagents each had a sensitivity and specificity of 100% compared with
the CDC reference antiserum. For 106 strains of E. coli and related organisms that were not enhanced for
motility through semisolid medium, the Remel H7 latex reagent had a sensitivity of 96% and a specificity of
100% compared with the standard tube agglutination method with CDC H7 antiserum. Measures to enhance
motility were needed for some strains to detect the H7 antigen. Our findings demonstrate that the commercial
latex reagents are good alternatives to standard serologic methods for identifying the O157 and H7 antigens
of E. coli.
objective of the study described here was to assess the sensitivities and specificities of several commercial latex reagents
for the identification of the O157 and H7 antigens of E. coli
O157:H7.
Included in the study were two latex reagent kits for the
identification of the O157 antigen (Oxoid Diagnostic Reagents, Hampshire, England; Pro-Lab Inc., Richmond Hill,
Ontario, Canada) and one latex reagent kit for the identification of both the O157 and the H7 antigens (Remel Microbiology Products, Lenexa, Kans.). The agglutination reactions
obtained with these latex reagents were compared with those
obtained by standard serologic methods with O157 or H7 reference rabbit antisera (Centers for Disease Control and Prevention [CDC], Atlanta, Ga.). A total of 159 strains (Table 1)
were tested. These strains were isolated from human stool
specimens and were identified by standard biochemical and
serologic tests (2). We randomly selected from our culture
collection E. coli strains, received between 1989 and 1993, that
possessed either the O157 or the H7 antigen, or both. We also
selected strains that possess cross-reacting antigens (1, 10) or
that were not able to ferment sorbitol within 48 h and that
could potentially be selected for screening from SMAC agar
(6).
For evaluation of the O157 latex reagents, bacterial cultures
frozen at 2708C were inoculated onto blood agar plates
(BAPs) and were then subcultured onto SMAC agar. A single
colony of bacterial growth from the SMAC agar plate was then
either tested in latex reagents for the O157 antigen or inoculated into broth for testing in the tube agglutination assay with
CDC O157 reference antiserum. The latex agglutination assays
were performed according to their manufacturers’ instructions.
A positive result with the O157 latex reagents was interpreted
as large clumps of agglutinated latex and bacteria with partial
or complete clearing of the background latex within 1 to 2 min.
The tube agglutination assay was performed as described by
Ewing (2), except that it was performed with fivefold less reagent in the microtiter plates. A positive result by the standard
serologic microtiter method with CDC O157 antiserum at its

Escherichia coli O157:H7 is now recognized as an important
human pathogen of public health concern. Since its recognition
in 1982, it has caused many outbreaks and sporadic cases of
diarrheal disease. Infection with E. coli O157:H7 may be inapparent or may result in a spectrum of disease ranging from
mild, nonbloody diarrhea to hemorrhagic colitis, which is characterized by severe abdominal cramping, bloody diarrhea, and
little or no fever (11). In some individuals, hemolytic-uremic
syndrome or thrombotic thrombocytopenic purpura may develop after infection (3, 4, 9, 11). The ability of this organism
to produce cytotoxins, referred to as Shiga toxins or Verocytotoxins, is believed to play an important role in the pathogenesis of hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura (3, 4).
E. coli O157:H7 infection is usually diagnosed by isolation of
the organism from stool specimens. Unlike approximately 80%
of other E. coli organisms, E. coli O157:H7 ferments sorbitol
slowly or not at all. This trait has been used by many to selectively test isolates for the O157 antigen. When E. coli O157:
H7 was first recognized as an enteric pathogen, screening of
sorbitol-negative isolates from sorbitol MacConkey (SMAC)
agar plates for the O157 antigen was performed with O157specific antiserum in slide or tube agglutination assays. In recent years, the development of latex reagents for the detection
of the O157 antigen has greatly facilitated the screening of
isolates for this antigen (7).
Although an E. coli isolate may be presumptively identified
as serotype O157:H7 after identification of only the O157
antigen, the complete identification of E. coli O157:H7 requires testing for both the O157 and the H7 antigens. Testing
for the H7 antigen is routinely performed by using H7-specific
antiserum in a tube agglutination assay. Recently, a latex reagent for the detection of the H7 antigen was developed. This
reagent would enable laboratories to make a complete identification of E. coli O157:H7 by a slide agglutination assay. The
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TABLE 1. Results for strains tested with commercial latex reagents and CDC antisera for the identification of
the O157 and H7 antigens of E. coli

Species

E. coli O157:H7
E. coli O157:NMe
E. coli O157:H12
E. coli O157:H16
E. coli O157:H45
E. coli O157:H45
E. coli O21:H7
E. coli O27:H7
E. coli O50:H7
E. coli O149:H7
E. coli Oundf:H7
E. coli non-O157:non-H7
E. hermannii
C. freundii
Salmonella O group N (O30)
S. enterica subsp. indica
Edwardsiella tarda
Hafnia alvei
Proteus spp.
Vibrio cholerae
Shigella spp.
Total strains tested

Sorbitol
fermentationa

2
2
1
2
1
2
1
1
1
1
1
2
2
1
1
2
2
2
2
1
2

No. of strains
tested for
O157

No. of strains agglutinated
by O157 reagents
Oxoid, Pro-Lab,
and Remel O157b

CDC O157
antiserum

60
14
1
3
4
1
0
0
0
0
0
0g
0
1
4
0g
0
0
0
0
0

60
14
1
3
4
1
0
0
0
0
0
0
0
1
4
0
0
0
0
0
0

60
14
1
3
4
1
1
2
1
1
1
2
10
1
4
10
1
1
2
10
29
159

No. of strains
tested for
H7

60
14
1
3
4
1
1
2
1
1
1
2
10
1
4

No. of strains
agglutinated by
H7 reagents
Remel
latex H7c

CDC H7
antiserumd

58
0
0
0
0
0
1
2
0
0
1
0
0
0
0

60
0
0
0
0
0
1
2
1
1
1
0
0
0
0

106

a

Sorbitol fermentation phenotype on SMAC agar after 24 h of incubation at 358C.
A single colony from SMAC agar was tested.
Sweep of bacterial growth from a BAP not enhanced for motility.
d
Tested after two to three passages through motility medium.
e
NM, nonmotile (no growth throughout motility medium after 7 days at 358C).
f
und, undetermined.
g
These strains were positive in test and control latex reagents and required heating to give interpretable results.
b
c

routine test dilution ($1:640) was interpreted as a mat of cells
in which at least 50% of the cells in the well were agglutinated.
The results of these tests are summarized in Table 1. The test
results obtained with all three O157 latex reagents were in
complete agreement with those obtained with the CDC reference O157 antiserum. Both the latex reagents and the CDC
reference O157 antiserum reacted with a strain of Citrobacter
freundii and all four strains of Salmonella O group N (O30),
which have previously been reported to possess antigens that
are serologically and chemically related to the O157 antigen (1,
5, 8). Although cross-reactions between some strains of Escherichia hermannii and E. coli O157 (10) have been noted previously, they were not observed with any of the O157 latex
reagents or the CDC reference O157 antiserum. We did observe nonspecific agglutination (i.e., agglutination of both the
test latex and the control latex) with two E. coli strains (sorbitol
negative, non-O157:non-H7) and 10 Salmonella enterica subsp.
indica strains. After boiling for 10 min, according to the manufacturers’ directions, we obtained negative results for these 12
strains.
When the present study was initiated, the optimal quantity
and type of antigen needed for the H7 latex agglutination assay
had not been determined. Using the test procedures recommended by the manufacturer and the criterion that we specified earlier for the interpretation of a positive agglutination
reaction with the O157 latex reagents, we evaluated several
different antigen preparations from 10 E. coli O157:H7 strains
to determine which one would be the most suitable for detecting the H7 antigen. First, we tested single colonies from the

SMAC agar plates described earlier and obtained negative
results for all 10 strains. To determine if these negative results
were attributable to poor motility, we passed the strains two
times through motility medium (0.4% [wt/vol] agar in nutrient
broth [Difco, Grand Rapids, Mich.]), subcultured growth from
the bottom of the second motility tube onto a BAP, and retested single colonies, as well as a sweep of growth ($2.5 mg of
growth), in the H7 latex reagent. The single colonies from the
motility-enhanced strains were unable to agglutinate the H7
latex reagent, but the sweeps of growth off of the BAP were all
positive in the H7 latex reagent; all broth antigens prepared
from growth from the second motility tube were positive in the
standard tube agglutination assay with CDC H7 antiserum.
These findings suggested that the amount of antigen contained
in a single colony is not sufficient to afford adequate agglutination of the H7 latex reagent.
Using the same strains, we then evaluated the H7 latex
reagent with sweeps of bacterial growth from a BAP before
and after enhancement of motility. Nine of 10 strains that were
not enhanced for motility and 10 of 10 strains that were enhanced for motility agglutinated the H7 latex.
Because the majority of strains in the preliminary evaluation
were agglutinated without enhancement of motility, we performed the evaluation of the H7 latex reagent using the manufacturers’ test procedures with a sweep of bacterial growth
from a BAP that was not enhanced for motility. Strains giving
false-negative results were retested after two to four passages
through motility medium. The H7 latex reagent reactions were
compared with those obtained by the standard tube agglutina-
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tion assay with CDC H7 antiserum (2). Overnight broth antigens prepared from strains passed two to three times through
motility medium were tested by the tube agglutination assay
with CDC reference H7 antiserum. A positive result with the
H7 antiserum at the routine test dilution (1:500) was interpreted as clumping of at least 50% or more of the bacterial
cells.
A subset of strains were selected for evaluating the H7 latex
reagent because of their reactivity in the O157 latex reagents
and/or the presence of the H7 antigen. The results for these
tests are summarized in Table 1. Of 106 strains tested with H7
latex reagents, 102 (96%) gave the expected results without
measures to enhance their motility; 62 of 66 (94%) strains
possessing the H7 antigen agglutinated the H7 latex, whereas
40 of 40 strains lacking the H7 antigen did not. Four E. coli
strains (O50:H7 [n 5 1], O149:H7 [n 5 1], and O157:H7 [n 5
2]) required four passages through motility medium before
they were sufficiently motile to agglutinate the H7 latex. One of
these (O157:H7) required three passages through motility medium before it was sufficiently motile to be agglutinated by the
CDC H7 antiserum, while the other 65 strains possessing the
H7 antigen were positive after two passages. These findings
demonstrate that expression of the H7 antigen can be variable
and that measures to enhance motility will be needed for some
strains to achieve adequate antigen expression for agglutination of the H7 latex reagent.
Since the majority of E. coli O157:H7 strains in the present
study agglutinated the H7 latex without enhancement of motility, we recommend that an O157-positive colony be subcultured first to blood or an equivalent agar and that a sweep of
growth from this medium be tested in the H7 latex assay. An E.
coli O157 isolate that is initially negative in the H7 latex reagent reaction should be retested after passage through appropriate medium to enhance motility. The number of passages
needed to achieve adequate antigen expression will vary from
strain to strain. For many strains, two passages are sufficient;
however, some E. coli O157:H7 strains received in our laboratory have required 10 or more passages to achieve adequate
flagellar antigen expression.
In our experience, enhancement of motility by subculturing
strains in semisolid medium can be problematic. The amount
of moisture and the concentration of agar in the medium are
factors that can dramatically influence the effectiveness of this
technique for increasing motility and antigen expression. If the
amount of moisture is too high or the concentration of agar is
too low, a strain may appear to be more motile than it actually
is. Testing of strains that are not sufficiently motile can lead to
false-negative results. For this reason, we advise having apparently motile E. coli O157 strains that do not agglutinate the H7
latex reagent tested for Shiga toxin production. Follow-up serologic testing of Shiga toxin-positive, motile O157 isolates is
desirable to identify new serotypes of Shiga toxin-producing E.
coli strains and to detect problems with procedures to enhance
the expression or detection of the H7 antigen. We also strongly
advise having E. coli O157 strains that are not motile tested for
Shiga toxin production, because 94% of such strains submitted
to our laboratory over the past 10 years have produced Shiga
toxins and were considered to be enterohemorrhagic E. coli
strains. Since nearly all strains of E. coli O157:H7 produce
Shiga toxin, we no longer encourage toxin testing of these
isolates for diagnostic purposes; however, in light of the recent
addition of E. coli O157:H7 infection to the list of reportable
infections in many states, we recommend that readers consult
their state health departments for advice on submitting E. coli
O157:H7 isolates for further testing.
One limitation of our study for predicting how the latex
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reagents would perform in a clinical setting is that we evaluated strains stocked in our culture collection rather than
freshly isolated bacteria. The percentage of slowly motile
strains that we encountered may not reflect what would be seen
in clinical specimens.
Compared with the reference method with CDC O157 antiserum, the Oxoid, ProLab, and Remel O157 latex reagents
each demonstrated 100% sensitivity and 100% specificity for
identifying the E. coli O157 antigen. Although some Salmonella and C. freundii strains possess antigens that cross-react
with the O157 antigen of E. coli, the identification of E. coli
O157 should not be compromised by this reactivity because the
other bacteria readily ferment sorbitol and can be biochemically distinguished from E. coli. By using a sweep of bacterial
growth without enhancement of motility, the Remel H7 latex
reagent test had a sensitivity of 96% and a specificity of 100%
compared with the reference method with CDC H7 antiserum.
Enhancement of antigen expression with up to four passages
through motility medium increased the sensitivity of the Remel
H7 latex reagent test to 100%. Our findings show that these
latex reagents, when used as directed by the manufacturers,
produce valid results for the strains included in the study and
are good alternatives to standard serologic methods for the
identification of the O157 and H7 antigens of E. coli.
Since the present study was completed, we received three
problematic strains for confirmation that appeared to give
false-positive reactions with the Remel O157 and H7 latex
reagents. It was not clear if single colonies or sweeps of growth
from these isolates were used on initial testing. When we tested
these isolates we used a lot number of latex reagent different
from the one used in the original evaluation. We used single
colonies from a SMAC agar plate or a BAP, as recommended
by the manufacturer, and found them all to be negative with
the Remel O157 latex reagent. However, when using sweeps of
growth from a SMAC agar plate or a BAP, these strains did
agglutinate in the Remel O157 latex reagent and were negative
in the control latex reagent. Since the control latex reagent was
negative, a positive result for O157 would have been recorded.
When these three strains were tested with CDC O157 antisera,
they were negative for O157. This shows that it is important to
closely follow the manufacturers’ directions when using any
latex reagent to avoid false readings; in this case, a single
colony is recommended. The three strains were also tested for
H7 by using sweeps of growth from a SMAC agar plate or a
BAP. The three strains agglutinated with the Remel H7 latex
reagent; however, two of the three strains, when tested with
CDC H7 antiserum, were not H7. It is therefore important that
the H7 latex reagent not be used independently of the O157
latex reagent. Strains should first be tested with the O157 latex
reagent, and if they are positive, they should then be tested
with the H7 latex reagent to avoid false-positive readings.
As testing for E. coli O157:H7 increases, it is likely that
organisms that were not anticipated for inclusion in this and
prior evaluations will be tested for the O157 and H7 antigens.
We would caution readers to be alert to reactions that do not
precisely conform to those described by the manufacturer and
to seek follow-up testing of isolates that yield atypical results
(e.g., stringy type agglutination) compared with the results for
controls.
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